The fabrication of artificial cardiac tissue is an active area of research due to the shortage of donors for heart transplantation and for drug development. In our previous study, we fabricated vascularized three-dimensional (3D) cardiac tissue by layer-by-layer (LbL) and cell accumulation technique. However, it was not able to develop sufficient function because it was cultured on a hard plastic substrate.
Experiment:
Herein, we report the fabrication of high-performance 3D cardiac tissue by LbL and cell accumulation technique using a collagen culture vessel.
Results:
By using a collagen culture vessel, 3D cardiac tissue could be fabricated on a collagen culture vessel and this tissue showed high functionality due to improved interaction with the vessel. In the case of the plastic culture insert, 3D cardiac tissue was found to be peeled off, but this did not occur on the collagen culture vessel. In addition, the 3D cardiac tissue fabricated on a collagen culture vessel showed contraction that was 20 times larger than the tissue fabricated on a plastic culture insert. As a result of evaluation of cardiotoxicity using E-4031, the sensitivity of arrhythmia detection was increased by using collagen culture vessel.
Conclusions:
These results are expected to contribute to transplantation and drug discovery research as a 3D cardiac tissue model with a function similar to that of the living heart.
Impact statement
In recent years, development of three-dimensional (3D) cardiac tissue has been promoted in regenerative medicine and drug discovery. In this study, we fabricated a 3D cardiac tissue composed of induced pluripotent stem cell (iPSC)-derived cardiomyocytes by the layer-by-layer (LbL) and cell accumulation technique. Furthermore, we worked on improving the function of the 3D cardiac tissue using the collagen culture vessel. As a result, the contractile function and the sensitivity of detecting arrhythmia by drugs of 3D cardiac tissue were improved. The 3D cardiac tissue fabricated in this study is expected to promote regenerative medicine and drug discovery.
Get full access to this article
View all access options for this article.
References
1.
LozanoR., NaghaviM., ForemanK., et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095, 2012.
2.
HaraguchiY., ShimizuT., YamatoM., and OkanoT.Regenerative therapies using cell sheet-based tissue engineering for cardiac disease. Cardiol Res Pract, 2011, 845170, 2011.
3.
OttH.C., MatthiesenT.S., GohS.K., et al.Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med, 14, 213–221, 2008.
4.
HughesJ.P., ReesS., KalindjianS.B., and PhilpottK.L.Principles of early drug discovery. Br J Pharmacol, 162, 1239, 2011.
5.
RothG.A., Dwyer-LindgrenL., Betozzi-VillaA., et al.Trends and patterns of geographic variation in cardiovascular mortality among US counties, 1980–2014. JAMA, 317, 1976, 2017.
6.
TkakashiK., TanabeK., OhnukiM., et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861, 2007.
7.
MummeryC.L., ZhangJ., NgE.S., ElliottD.A., ElefantyA.G., and KampT.J.Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res, 111, 344, 2012.
8.
KattmanS.J., WittyA.D., GagliardiM., et al.Stage-specific optimization of activing, nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8, 228, 2011.
9.
ShimizuT., YamatoM., KikuchiA., and OkanoT.Cell sheet engineering for myocardial tissue reconstruction. Biomaterials, 24, 2309, 2003.
10.
NirmalanandhanV.S., Sittampalam. G.S. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges. J Bioml Screen, 14, 755, 2009.
11.
EbertA.D., and SvendsenC.N.Human stem cells and drug screening: opportunities and challenges. Nat Rev Discov, 9, 367, 2010.
12.
HubbellJ.A.Biomaterials science and high-throughput screening. Nat Biotechnol, 22, 828, 2004.
13.
YamatoM., and OkanoT.Cell sheet engineering. Mater Today, 7, 42, 2004.
14.
MiyagawaS., SawaY., SakakidaS., et al.Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation, 80, 1586, 2005.
15.
MatsuuraK., WadaM., ShimizuT., et al.Creation of human cardiac cell sheets using pluripotent stem cells. Biochem Biophys Res Commum, 425, 321, 2012.
16.
ShimizuT., YamatoM., IsoiY., et al.Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res, 90, e40, 2002.
17.
RavenscroftS.M., PointonA., WilliamsA.W., CrossM.J., and SidawayJ.E.Cardiac non-myocyte cells show enhanced pharmacological function suggestive of contractile maturity in stem cell derived cardiomyocyte microtissues. Toxicol Sci, 152, 99, 2016.
18.
DesrochesB.R., ZhangP., ChoiB.R., et al.Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells. Am J Physiol Heart Circ Physiol, 302, H2031, 2012.
19.
VukusicK., JonssonM., BrantsingC., et al.High density sphere culture of adult cardiac cells increases the levels of cardiac and progenitor markers and shows signs of vasculogenesis. Biomed Res Int, 2013, 696837, 2013.
20.
LiJ., MinamiI., ShiozakiM., et al.Human pluripotent stem cell-derived cardiac tissue-like constructs for repairing the infarcted myocardium. Stem Cell Rep, 9, 1546, 2017.
21.
YasuiH., LeeJ.K., YoshidaA., et al.Excitation propagation in three-dimensional engineered hearts using decellularized extracellular matrix. Biomaterials, 35, 7839, 2014.
22.
LuT.Y., LinB., KimJ., et al.Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat Commun, 4, 2307, 2013.
23.
RussoV., OmidiE., SamaniA., HamiltonA., and FlynnL.E.Porous, ventricular extracellular matrix-derived foams as a platform for cardiac cell culture. Biores Open Access, 4, 374, 2015.
24.
WilliamsC., QuinnK.P., GeorgakoudiI., andBlack, 3rdL.D.Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro. Acta Biomater, 10, 194, 2014.
25.
ZimmermannW.H., FinkC., KralischD., RemmersU., WeilJ., and EschenhagenT.Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng, 68, 106, 2000.
26.
ZimmermannW.H., MelnychenkoI., and EschenhagenT.Engineered heart tissue for regeneration of diseased hearts. Biomaterials, 25, 1639, 2004.
27.
EschenhagenT., FinkC., RemmersU., et al.Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB, 11, 683, 1997.
28.
ZhangD., ShadrinI.Y., LamJ., XianH.Q., SnodgrassH.R., and BursacN.Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials, 34, 5813, 2013.
29.
NakaneT., MasumotoH., TinneyJ.P., et al.Impact of cell composition and geometry on human induced pluripotent stem cells-derived engineered cardiac tissue. Sci Rep, 7, 45641, 2017.
30.
XuT., BaicuC., AhoM., ZileM., and BolandT.Fabrication and characterization of bio-engineered cardiac pseudo tissues. Biofabrication, 1, 035001, 2009.
31.
AraiK., YoshidaT., OkabeM., et al.Fabrication of 3D-culture platform with sandwich architecture for preserving liver-specific functions of hepatocytes using 3D bioprinter. J Biomed Mater Res A, 105, 1538, 2017.
32.
BayomyA.F., BauerM., QiuY., and LiaoR.Regeneration in heart disease—is ECM the key? Life Sci, 91, 823, 2012.
33.
BowersS.L., BanerjeeI., and BaudinoT.A.The extracellular matrix: at the center of it all. J Mol Cell Cardiol, 48, 474, 2010.
34.
HandorfA.M., ZhouY., HalanskiM.A., and LiW.J.Tissue stiffness dictates development, homeostasis, and disease progression. Organogenesis, 11, 1, 2015.
35.
ArshiA., NakashimaY., NakanoH., et al.Rigid microenvironments promote cardiac differentiation of mouse and human embryonic stem cells. Sci Technol Adv Mater, 14, 025003, 2013.
Even-RamS., ArtymV., and YamadaK.M.Matrix control of stem cell fate. Cell, 126, 645, 2006.
38.
EnglerA.J., Carag-KriegerC., JohnsonC.P., et al.Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci, 121, 3794, 2008.
MatsusakiM., KadowakiK., NakaharaY., and AkashiM.Fabrication of cellular multilayers with nanometer-sized extracellular matrix films. Angew Chem Int Ed Engl, 46, 4689, 2007.
41.
NishiguchiA., YoshidaH., MatsusakiM., and AkashiM.Rapid construction of three-dimensional multilayered tissues with endothelial tube networks by the cell-accumulation technique. Adv Mater, 23, 3506, 2011.
42.
NishiguchiA., MatsusakiM., AsanoY., ShimodaH., and AkashiM.Effects of angiogenic factors and 3D-microenvironments on vascularization within sandwich cultures. Biomaterials, 35, 4739, 2014.
43.
MatsusakiM., FujimotoK., ShirakataY., HirakawaS., HashimotoK., and AkashiM.Development of full-thickness human skin equivalents with blood and lymph-like capillary networks by cell coating technology. J Biomed Mater Res A, 103, 3386, 2015.
44.
NishiguchiA., MatsusakiM., KanoM.R., et al.In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis. Biomaterials, 179, 144, 2018.
45.
AkagiT., NaguraM., HiuraA., KojimaH., and AkashiM.Construction of three-dimensional dermo-epidermal skin equivalents using cell coating technology and their utilization as alternative skin for permeation studies and skin irritation tests. Tissue Eng Part A, 23, 481, 2017.
46.
MatsuzawaA., MatsusakiM., and AkashiM.Construction of three-dimensional liver tissue models by cell accumulation technique and maintaining their metabolic functions for long-term culture without medium change. J Biomed Mater Res A, 103, 1554, 2015.
47.
SasakiK., AkagiT., AsaokaT., et al.Construction of three-dimensional vascularized functional human liver tissue using a layer-by-layer cell coating technique. Biomaterials, 133, 263, 2017.
48.
MatsusakiM., SakaueK., KadowakiK., and AkashiM.Three-dimensional human tissue chips fabricated by rapid and automatic inkjet cell printing. Adv Healthc Mater, 2, 534, 2013.
49.
MatsusakiM., HikimotoD., NishiguchiA., KadowakiK., ImaiT., and AkashiM.3D-fibroblast tissues constructed by a cell-coat technology enhance tight-junction formation of human colon epithelial cells. Biochem Biophys Res Commun, 457, 363, 2015.
50.
FukudaY., AkagiT., AsaokaT., et al.Layer-by-layer cell coating technique using extracellular matrix facilitates rapid fabrication and function of pancreatic β-cell spheroids. Biomaterials, 160, 82, 2018.
51.
NishiyamaK., AkagiT., IwaiS., and AkashiM.Construction of vascularized oral mucosa equivalents using a layer-by-layer cell coating technology. Tissue Eng Part C Methods, 25, 262, 2019.
52.
GuerzoniL.P.B., TsukamotoY., GehlenD.B., et al.A layer-by-layer single-cell coating technique to produce injectable beating mini heart tissues via microfluidics. Biomacromolecules, 20, 3746, 2019.
53.
AmanoY., NishiguchiA., MatsusakiM., et al.Development of vascularized iPSC derived 3D-cardiomyocyte tissues by filtration Layer-by-Layer technique and their application for pharmaceutical assays. Acta Biomater, 33, 110, 2016.
54.
TakedaT., MiyagawaS., FukushimaS., et al.Development of in vitro drug-induced cardiotoxicity assay by using three-dimensional cardiac tissues derived from human induced pluripotent stem cells. Tissue Eng Part C Methods, 24, 56, 2018.
55.
MiyaokaA., TsukamotoY., TakagiD., SeoM., MiyagawaS., AkashiM. Noninvasive OCT imaging of three-dimensional cardiac tissues derived from human induced pluripotent stem cells. J Tissue Eng Regen Med, 2020. In press.
56.
NaritaH., ShimaF., YokoyamaJ., et al.Engraftment and morphological development of vascularized human iPS cell-derived 3D-cardiomyocyte tissue after xenotransplantation. Sci Rep, 7, 13708, 2017.
57.
TsukamotoY., AkaghiT., ShimaF., and AkashiM.Fabrication of orientation-controlled 3D tissues using a layer-by-layer technique and 3D printed a thermoresponsive gel frame. Tissue Eng Part C Methods, 23, 357, 2017.
58.
TsukamotoY., AkagiT., and AkashiM.Vascularized cardiac tissue construction with orientation by layer-by-layer method and 3D printer. Sci Rep, 10, 5484, 2020.
59.
LiuC.Y., MatsusakiM., and AkashiM.Three-dimensional tissue models constructed by cells with nanometer- or micrometer-sized films on the surfaces. Chem Rec, 16, 783, 2016.
60.
LiuC.Y., MatsusakiM., and AkashiM.Control of cell–cell distance and cell densities in millimeter-sized 3D tissues constructed by collagen nanofiber coating techniques. ACS Biomater Sci Eng, 1, 639, 2015.
61.
SasanoY., FukumotoK., TsukamotoY., AkagiT., and AkashiM.Construction of 3D cardiac tissue with synchronous powerful beating using human cardiomyocytes from human iPS cells prepared by a convenient differentiation method. J Biosci Bioeng, 129, 749, 2020.
62.
NakagawaM., KoyanagiM., TakahashiK., et al.Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol, 26, 101, 2008.
63.
RasbandW.S. ImageJ. U.S. Maryland, USA: National Institutes of Health, Bethesda. http://rsb.info.nih.gov/ij/, 1997–2012 (accessed September10, 2020).
64.
TsengQ., Duchemin-PelletierE., DeshiereA., et al.Spatial organization of the extracellular matrix regulates cell-cell junction positioning. Proc Natl Acad Sci U S A, 109, 1506, 2012.
65.
HayakawaT., KunihiroT., AndoT., et al.Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: correlation and complementarity with extracellular electrophysiology. J Mol Cell Cardiol, 77, 178, 2014.
66.
BellE., IvarssonB., and MerrillC.Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A, 76, 1274, 1979.
67.
GaudetC., MarganskiW.A., KimS., et al.Influence of type I collagen surface density on fibroblast spreading, motility, and contractility. Biophys J, 85, 3329, 2003.
68.
DunnJ.C., TompkinsR.G., and YarmushM.L.Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog, 7, 237, 1991.
69.
YamadaK.M.Cell surface interactions with extracellular materials. Annu Rev Biochem, 52, 761, 1983.
70.
MouwJ.K., OuG., and WeaverV.M.Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol, 15, 771, 2014.
71.
HörningM., KidoakiS., KawanoT., and YoshikawaK.Rigidity matching between cells and the extracellular matrix leads to the stabilization of cardiac conduction. Biophys J, 102, 379, 2012.
72.
McCainM.L., YuanH., PasqualiniF.S., CampbellP.H., and ParkerK.K.Matrix elasticity regulates the optimal cardiac myocyte shape for contractility. Am J Physiol Heart Circ Physiol, 306, H1525, 2014.
73.
YangX., PabonL., and MurryC.E.Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res, 114, 511, 2014.
74.
MillsR.J., and HudsonJ.E.Bioengineering adult human heart tissue: how close are we? APL Bioeng, 3, 010901, 2019.
75.
ScuderiG.J., and ButcherJ.Naturally engineered maturation of cardiomyocyte. Front Cell Dev Biol, 5, 50, 2017.
76.
KawatouM., MasumotoH., FukushimaH., et al.Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart Tissue. Nat Commun, 8, 1078, 2017.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
